Based on the survival data of the pure IMPC and IBC-NST cases claudin-4 positive tumors were associated with significantly shorter DMFS, suggesting a role of claudin-4 in cancer progression. The gene discussed is CLDN4; the disease is inflammatory breast carcinoma.